Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-06-03
1999-11-02
Housel, James C.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 2432, 536 243, 530350, 435 691, 435 693, 435 694, 4242561, C07H 2104
Patent
active
059773375
ABSTRACT:
Purified and isolated nucleic acid molecules are provided which encode lactoferrin receptor proteins of Moraxella, such as M. catarrhalis, or a fragment or an analog of the lactoferrin receptor protein. The nucleic acid sequence may be used to produce recombinant lactoferrin receptor proteins Lbp1, Lbp2 and Lbp3 of the strain of Moraxella free of other proteins of the Moraxella strain for purposes of diagnostics and medical treatment. Furthermore, the nucleic acid molecule may be used in the diagnosis of infection.
REFERENCES:
patent: 4258029 (1981-03-01), Moloney et al.
patent: 4855283 (1989-08-01), Lockhoff et al.
patent: 4952496 (1990-08-01), Studier et al.
patent: 5194254 (1993-03-01), Barber et al.
Du, R-P et al; vol. 66, No. 8, Aug. 1998; pp. 3656-3665.
Brorson, J-E., A. Axelsson, and S.E. Holm. 1976. Studies on Branhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scan. J. Infect. Dis. 8:151-155.
Catlin, B.W., 1990. Branhamella catarrhalis:an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3: 293-320.
Hager, H., A. Verghese, S. Alvarez, and S.L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149.
McLeod, D.T., F. Ahmad, M.J. Croughan, and M.A. Calder. 1986. Bronchopulmonary infection due to M. catarrhalis. Clinical features and therapeutic respsonse. Drugs 31(Suppl.3):109-112.
Nicotra, B., M. Rivera, J.I. Luman, and R.J. Wallace. 1986. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch.Intern.Med. 146:890-893.
Ninane, G., J. Joly, and M. Kraytman. 1978. Bronchopulmonary infection due to Branhamella catarrhalis 11 cases assessed by transtracheal puncture. Br.Med.Jr. 1:276-278.
Srinivasan, G., M.J. Raff, W.C. Templeton, S.J. Givens, R.C. Graves, and J.C. Mel. 1981. Branhamella catarrhalis pneumonia. Report of two cases and review of the literature. Am. Rev. Respir. Dis. 123:553-555.
West, M., S.L. Berk, and J.K. Smith. 1982. Branhamella catarrhalis pneumonia., South Med. J. 75:1021-1023.
Christensen, J.J., and B. Bruun. 1985. Bacteremia caused by a beta-lactamase producing strain of Branhamella catarrhalis. Acta. Pathol. Microbiol. Immunol. Scand. Sect. B 93:273-275.
Craig, D.B., and P.A. Wehrle. 1983. Branhamella catarrhalis septic arthritis. J. Rheumatol. 10:985-986.
Guthrie, R., K. Bakenhaster, R. Nelson, and R. Woskobnick. 1988. Branhamella catarrhalis sepsis: a case report and review of the literature. J. Infect. Dis. 158:907-908.
Hiroshi, S., E.J. Anaissie, N. Khardori, and G.P. Bodey. 1988. Branhamella catarrhalis septicemia in patients with leukemia. Cancer 61:2315-2317.
O'Neill, J.H., and P.W. Mathieson. 1987. Meningitis due to Branhamella catarrhalis. Aust. N.Z. J. Med. 17:241-242.
Murphy, T.F. 1989. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr. Infect. Dis. J. 8:S75-S77.
Van Hare, G.F., P.A. Shurin, C.D. Marchant, N.A. Cartelli, C.E.Johnson, D. Fulton, S. Carlin, and C.H. Kim. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev. Infect. Dis. 9:16-27.
Jorgensen, J.H., Doern, G.V., Maher, L.A., Howell, A.W., and Redding, J.S., 1990 Antimicrobial resistance among respiratory isolates of Haemophilus influenza, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antibicrob. Agents Chemother. 34: 2075-2080.
Schryvers, A.B. and Lee, B.C. (1988) Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae. Can. J. Microbiol. 35, 409-415.
O'Hagan, DT. 1992. Oral deleivery of vaccines. Formulation and clinical pharmaco kinetic considerations. Clin. Pharmacokinet 22(t): 1-10.
Ulmer et al. 1993. Curr. Opinion Invest. Drugs 2:983-989.
Lockhoff, O., Glycolipids as immunomodulators: Synthesis and properties, 1991, pp. 1611-1630.
Nixon-George A., et al., 1990. The adjuvant effect of stearyl tyrosine on a recombinant subunit hepatitis B surface antigen. J Immunol 144 (12): 4798-4802.
Wallace, R.J. et al., 1990. Antibiotic susceptibilities and drug resistance in Moraxella (Branhaemella) catarrhalis. Am. J. Med. 88(5A):465-505.
Nissinen A, et al., 1995. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin. Infect Dis 21 (5): 1193-1196.
Pettersson, A., et al., 1994. Identification of iroa Gene Product of Neisseria meningitides as a Lactoferrin Receptor. J. Bacteriol. 176(6): 1764-1766.
Biswas GD, Sparring PF. 1995. Characterization of 1bpa, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Inimun 63 (8): 2958-2967.
Legrain M, et al. 1993. Cloning and characterization of Neisseria meningitides genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene 130 (1): 73-80.
Cornelissen CN, Biswas GD, Sparling PF. 1993. Expression of gonococcal transferrin-binding protein 1 causes Escherichia coli to bind human transferrin. J Bacteriol 175 (8): 2448-2450.
Anderson JE, Sparling PF, Cornelissen CN. 1994. Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J Bacteriol 176 (11):3162-3170.
Ogunnariwo JA, Schryvers AB. 1996. Rapid identification and cloning of bacterial transferrin ad lactoferrin receptor protein genes. J Bacteriol 178 (24): 7326-7328.
Loosmore SM, et al. 1996. Cloning and expression of the Haemophilus influenzae transferrin receptor genes. Mol Microbiol 19 (3): 575-586.
Pettersson, A. et al. 1993. Molecular Characterization of the 98-Kilodalton Iron-Regulated Outer membrane Protein of Neisseria meningitides. Infect. Immun. 61 (ti): 4724-4733.
Du Run-Pan
Klein Michel H.
Loosmore Sheena M.
Wang Quijun
Yang Yan-Ping
Connaught Laboratories Limited
Graser Jennifer
Housel James C.
LandOfFree
Lactoferrin receptor genes of Moraxella does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactoferrin receptor genes of Moraxella, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactoferrin receptor genes of Moraxella will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2137146